Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria vaccine development: progress and challenges.

Z H Reed1, M Friede, M P Kieny

  • 1Initiative for Vaccine Research, World Health Organization, Department of Immunizations, Vaccines & Biologicals, 20 Avenue Appia, CH-1211 Geneva, Switzerland. reedz@who.int

Current Molecular Medicine
|March 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TBMaLT, a flexible toolkit for combining tight-binding and machine learning.

The Journal of chemical physics·2023
Same author

[Rank of outcome parameters in the treatment of depression : Results of a Delphi panel survey].

Der Nervenarzt·2016
Same author

Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-analysis - Comment to Naudet.

Pharmacopsychiatry·2016
Same author

Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.

Pharmacopsychiatry·2016
Same author

Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease.

European review for medical and pharmacological sciences·2014
Same author

Treatment of comorbid anxiety and depression with escitalopram: results of a post-marketing surveillance study.

Pharmacopsychiatry·2012
Same journal

Corrigendum to: Sortilin as a Culprit in the Atherosclerosis Plaque Progression: Evidence from Clinical and Experimental Studies.

Current molecular medicine·2026
Same journal

Dynamic Expression of Fibroblast Activation Protein (FAP) During Chronic Pancreatitis (CP) Progression in Mice and Evaluation of FAP-targeted Tracers for Early CP Diagnosis.

Current molecular medicine·2026
Same journal

Causal Relationship Between 91 Inflammatory Factors and Gastritis: A Two-Sample Bidirectional Mendelian Randomization Study.

Current molecular medicine·2026
Same journal

Therapeutic Potential of Pistacia Atlantica Gum in Aspirin-Induced Peptic Ulcers: A Dose-Dependent Approach to Mucosal Protection and Hepatorenal Safety.

Current molecular medicine·2026
Same journal

Identification and Characterization of MicroRNAs Associated with Borax-mediated Anti-tumor Activity through High-throughput Technology.

Current molecular medicine·2026
Same journal

Broad-Spectrum Vaccines: Challenges and Opportunities (A Systematic Review).

Current molecular medicine·2026
See all related articles

Developing a safe and effective malaria vaccine faces significant hurdles, including slow progress and a lack of understanding regarding protective immunity. Addressing these challenges is critical for impactful disease control in developing nations.

Area of Science:

  • Malariology
  • Vaccinology
  • Infectious Disease Research

Background:

  • A safe and effective malaria vaccine is crucial for disease control and prevention.
  • Despite global efforts, malaria vaccine development has progressed slowly.

Purpose of the Study:

  • To review current malaria vaccine candidates, particularly those in clinical trials.
  • To identify and explain the challenges hindering malaria vaccine development and evaluation.

Main Methods:

  • Review of global malaria vaccine development activities.
  • Emphasis on clinical-stage vaccine candidates.
  • Analysis of challenges in vaccine creation and assessment.

Main Results:

  • Significant activity exists in malaria vaccine development, but progress is slow.

Related Experiment Videos

  • Numerous challenges impede the development and evaluation of malaria vaccines.
  • Lack of knowledge on protective immunity and reliable surrogates of protection are key obstacles.

    • Conclusions:

    • Current research and development strategies may not yield a vaccine impactful enough for developing countries.
    • Unambiguously identifying and collectively addressing the main challenges is critical for malaria vaccine advancement.